TITLE

Pathology: Two of a kind

AUTHOR(S)
Atkinson, Sophie
PUB. DATE
June 2011
SOURCE
Nature Reviews Cancer;Jun2011, Vol. 11 Issue 6, p390
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses research being done on muscular dystrophies. It references the study "DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in Muscular Dystrophies" by W. M. Schmidt and colleagues in the 2011 issue. Commonly mutated muscular dystrophy-associated genes such as dystrophin (Dmd), and dysferlin (Dysf) were observed using mouse models. Results show that dystrophies in both humans and mice share common pathology of cancer-like DNA damage and genomic instability.
ACCESSION #
60832161

 

Related Articles

  • Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. McClorey, G.; Moulton, H. M.; Iversen, P. L.; Fletcher, S.; Wilton, S. D. // Gene Therapy;Oct2006, Vol. 13 Issue 19, p1373 

    Manipulation of pre-mRNA splicing by antisense oligonucleotides (AOs) offers considerable potential for a number of genetic disorders. One of these is Duchenne muscular dystrophy (DMD), where mutations in the dystrophin gene typically result in premature termination of translation that causes a...

  • Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization. Seno, Mohammad M. Ghahramani; Trollet, Capucine; Athanasopoulos, Takis; Graham, Ian R.; Pingzhao Hu; Dickson, George // BMC Genomics;2010, Vol. 11, p345 

    Background: Duchenne muscular dystrophy (DMD) is a fatal muscle wasting disorder caused by mutations in the dystrophin gene. DMD has a complex and as yet incompletely defined molecular pathophysiology hindering development of effective ameliorative approaches. Transcriptomic studies so far...

  • A Duchenne Muscular Dystrophy Gene Hot Spot Mutation in Dystrophin-Deficient Cavalier King Charles Spaniels Is Amenable to Exon 51 Skipping. Walmsley, Gemma L.; Arechavala-Gomeza, Virginia; Fernandez-Fuente, Marta; Burke, Margaret M.; Nagel, Nicole; Holder, Angela; Stanley, Rachael; Chandler, Kate; Marks, Stanley L.; Muntoni, Francesco; Shelton, G. Diane; Piercy, Richard J. // PLoS ONE;2010, Vol. 5 Issue 1, p1 

    Background: Duchenne muscular dystrophy (DMD), which afflicts 1 in 3500 boys, is one of the most common genetic disorders of children. This fatal degenerative condition is caused by an absence or deficiency of dystrophin in striated muscle. Most affected patients have inherited or spontaneous...

  • Utility of MLPA in mutation analysis and carrier detection for Duchenne muscular dystrophy. Verma, Prashant K.; Dalal, Ashwin; Mittal, Balraj; Phadke, Shubha R. // Indian Journal of Human Genetics;Jan-Apr2012, Vol. 18 Issue 1, p91 

    CONTEXT: Multiplex ligation probe amplification (MLPA) is a new technique to identify deletions and duplications and can evaluate all 79 exons in dystrophin gene in patients with Duchenne muscular dystrophy (DMD). Being semiquantitative, MLPA is also effective in detecting duplications and...

  • Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform. Byung Chan Lim; Lee, Seungbok; Jong-Yeon Shin; Jong-Il Kim; Hee Hwang; Ki Joong Kim; Yong Seung Hwang; Jeong-Sun Seo; Jong Hee Chae // Journal of Medical Genetics;Nov2011, Vol. 48 Issue 11, p731 

    Background Duchenne muscular dystrophy or Becker muscular dystrophy might be a suitable candidate disease for application of next-generation sequencing in the genetic diagnosis because the complex mutational spectrum and the large size of the dystrophin gene require two or more analytical...

  • Congenital Muscular Dystrophy in Israeli Families. Rachmiel, Marianna; Nevo, Yoram; Lahat, Eli; Kutai, Miriam; Harel, Shaul; Shahar, Eli // Journal of Child Neurology;May2002, Vol. 17 Issue 5, p333 

    Twelve patients from 11 Israeli families with congenital muscular dystrophy were evaluated between 1991 and 2001. There were six males and six females, of whom six were merosin negative and six were merosin positive. Serum creatine kinase levels were highly elevated in the merosin-negative...

  • Knocking signalling out of the dystrophin complex. Bredt, David S. // Nature Cell Biology;Aug99, Vol. 1 Issue 4, pE89 

    Mice lacking dystrobrevin, a dystrophin-associated protein, exhibit a new form of muscular dystrophy in which the integrity of muscle fibres is maintained, but a component of muscle-cell signalling is disrupted.

  • Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy Griffin, J.L.; Sang, E.; Evens, T.; Davies, K.; Clarke, K. // FEBS Letters;Oct2002, Vol. 530 Issue 1-3, p109 

    Metabolic profiles from 1H nuclear magnetic resonance spectroscopy have been used to describe both one and two protein systems in four mouse models related to Duchenne muscular dystrophy using the pattern recognition technique partial least squares. Robust statistical models were built for...

  • Recent advances in Duchenne muscular dystrophy. Perkins, Kelly J.; Davies, Kay E. // Degenerative Neurological & Neuromuscular Disease;2012 Part 2, Vol. 2, p141 

    Duchenne muscular dystrophy (DMD), an allelic X-linked progressive muscle-wasting disease, is one of the most common single-gene disorders in the developed world. Despite knowledge of the underlying genetic causation and resultant pathophysiology from lack of dystrophin protein at the muscle...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics